(Q42375830)

28 October 2017

Genetic evidence of PTPN22 effects on chronic lymphocytic leukemia (English)

1 reference

28 October 2017

0 references

19

1 reference

28 October 2017

9

Timothy G Call

1 reference

28 October 2017

2

Susan L Slager

1 reference

28 October 2017

10

Kari G Rabe

1 reference

28 October 2017

11

Neil E Kay

1 reference

28 October 2017

7

Sara J Achenbach

1 reference

28 October 2017

14

Nicola J Camp

1 reference

28 October 2017

Scott J Hebbring

1

1 reference

28 October 2017

Narendranath Epperla

3

1 reference

28 October 2017

Joseph J Mazza

4

1 reference

28 October 2017

Zhan Ye

5

1 reference

28 October 2017

Zhiyi Zhou

6

1 reference

28 October 2017

Daniel A Vasco

8

1 reference

28 October 2017

Neil E Caporaso

12

1 reference

28 October 2017

Mark C Lanasa

13

1 reference

28 October 2017

Sara S Strom

15

1 reference

28 October 2017

Lynn R Goldin

16

1 reference

28 October 2017

James R Cerhan

17

1 reference

28 October 2017

Murray H Brilliant

18

1 reference

28 October 2017

language of work or name

English

0 references

publication date

1 January 2013

1 reference

28 October 2017

2

1 reference

based on heuristic

inferred from page(s)

published in

Blood

1 reference

28 October 2017

121

1 reference

28 October 2017

1

1 reference

28 October 2017

237-238

1 reference

Overexpression of the autoimmunity-associated phosphatase PTPN22 promotes survival of antigen-stimulated CLL cells by selectively activating AKT.

28 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5091216

The PTPN22 allele encoding an R620W variant interferes with the removal of developing autoreactive B cells in humans

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5091216

Genome-wide association study identifies a novel susceptibility locus at 6p21.3 among familial CLL

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5091216

Autoimmune-associated PTPN22 R620W variation reduces phosphorylation of lymphoid phosphatase on an inhibitory tyrosine residue

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5091216

Lymphoid tyrosine phosphatase and autoimmunity: human genetics rediscovers tyrosine phosphatases

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5091216

Cutting edge: the PTPN22 allelic variant associated with autoimmunity impairs B cell signaling

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5091216

A functional variant of lymphoid tyrosine phosphatase is associated with type I diabetes

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5091216

Autoimmunity in primary antibody deficiency is associated with protein tyrosine phosphatase nonreceptor type 22 (PTPN22).

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5091216

The autoimmune disease-associated PTPN22 variant promotes calpain-mediated Lyp/Pep degradation associated with lymphocyte and dendritic cell hyperresponsiveness.

16 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5091216

Marshfield Clinic Personalized Medicine Research Project (PMRP): design, methods and recruitment for a large population-based biobank

16 August 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23287625

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1182/BLOOD-2012-08-450221

1 reference

28 October 2017

1 reference

28 October 2017

PubMed publication ID

23287625

1 reference